An Observational Follow-up Study of 1st-Line Treatment With Herceptin (Trastuzumab) in Patients With Metastatic Breast Cancer (Post-HERMINE)
Clinical trial NCT01332981 · COMPLETED
Trial details
- NCT number
- NCT01332981
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-02-01
- Primary completion
- 2010-10-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.